The US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS) Program – Current Status and Future Direction
Year: 2016
Type: article
Source: Clinical Therapeutics
Authors: Jasmanda Wu, Juhaeri Juhaeri
Institution: Sanofi (United States)
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
Funder: Sanofi
OpenAlex ID: W2559699774
